Tag: Vaccines
Panacea Biotec donates 125,000 doses of Easyfive-TT to Cuba
This donation will allow the continuation of the cycle of vaccination for children foreseen within the national immunization program carried out by the Ministry of Public Health of Cuba
BioVoice eMagazine January 2023 Issue 1 Volume 4
Click to Read: January 2023 Edition of BioVoice eMagazine
BioVoice News, India's leading B2B news media for BioTech, HealthTech and AgriTech, is celebrating its 7th anniversary...
The Rising Vaccine Superpower: India’s phenomenal rise in the new vaccine...
Garnering a massive chunk of revenue owing to Covid-19 push, India’s indigenous vaccines now proudly dominate the biopharma segment. Here we analyze the fresh impetus and the outlook
BSV expands footprint in Malaysia, to acquire Firstline Pharma & Genomicks
With the move, Bharat Serums and Vaccines Limited (BSV) aims at deepening its presence in South-East Asia
BioVoice eMagazine December 2022 Issue 3 Volume 3
Click to Read: BioVoice eMagazine December 2022 Issue 3 Volume 3
The Cover Story in the current edition focuses on India's strong biotech R&D segment...
Indian Immunologicals ventures into fish vaccines segment
IIL partners with Central Institute of Fisheries Education, an Indian Council of Agricultural Research Institute for the commercial development of vaccine against common bacterial diseases in freshwater fishes
Indian Immunologicals to invest Rs 700 crore in Hyderabad for new...
The company is investing in a new greenfield project for the establishment of a Veterinary Vaccine Facility for manufacturing of Foot and Mouth Disease (FMD) vaccine and other animal vaccines
Indian Immunologicals hosts massive anti-rabies vaccine drive
On World Zoonosis Day 2022, the company administered 1 lakh free vaccines in nationwide vaccination camps at around 100 cities
BSV forges collaboration with NCL-Pune to co-develop biopharma products
This collaboration primarily focuses on evaluation of certain recombinant cell line technologies developed by NCL for biopharmaceutical products currently under development at BSV
Age-based eligibility method to measure vaccine effectiveness in data-deficient scenarios
The current vaccine effectiveness study efforts tend to be skewed toward the world's more affluent countries